WO2009058564A3
Immunosuppressive polypeptides and nucleic acids
Abstract
The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO0202638A2 | Cites | World Intellectual Property Organization (WIPO) | X | International search | 1 |
| WO2005017148A1 | Cites | World Intellectual Property Organization (WIPO) | X | International search | 1,53 |
| WO2008047150A2 | Cites | World Intellectual Property Organization (WIPO) | PX | International search | 1 |
57 members in 21 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 98463107 | United States of America | P | |
| 98463107 | United States of America | P | |
| 5121508 | United States of America | P | |
| 5121508 | United States of America | P | |
| 60984631 | – | – | – |
| 61051215 | – | – | – |
| US20070984631P | – | – | – |
| US20080051215P | – | – | – |
Members57
| Document | Office | Kind | |
|---|---|---|---|
| AU2008319053A1 | Australia | A1 | |
| CA2703263A1 | Canada | A1 | |
| CA2805976A1 | Canada | A1 | |
| WO2009058564A2 | World Intellectual Property Organization (WIPO) | A2 | |
| TW200936607A | Taiwan Province of China | A | |
| US2009258031A1 | United States of America | A1 | |
| WO2009058564A3This record | World Intellectual Property Organization (WIPO) | A3 | |
| EP2222697A2 | European Patent Office (EPO) | A2 | |
| US7794718B2 | United States of America | B2 | |
| KR20100105551A | Republic of Korea | A | |
| US2010260759A1 | United States of America | A1 | |
| MX2010004883A | Mexico | A | |
| JP2011502479A | Japan | A | |
| ZA201002872B | South Africa | B | |
| CN101998965A | China | A | |
| US2011129875A1 | United States of America | A1 | |
| US2011130546A1 | United States of America | A1 | |
| US2011159542A1 | United States of America | A1 | |
| US2011166324A1 | United States of America | A1 | |
| US2011177071A1 | United States of America | A1 | |
| US2011182898A1 | United States of America | A1 | |
| EP2385065A1 | European Patent Office (EPO) | A1 | |
| US8071095B2 | United States of America | B2 | |
| RU2010122053A | Russian Federation | A | |
| AU2008319053B2 | Australia | B2 | |
| US8268587B2 | United States of America | B2 | |
| US8283447B2 | United States of America | B2 | |
| US8318176B2 | United States of America | B2 | |
| EP2222697B1 | European Patent Office (EPO) | B1 | |
| PT2222697E | Portugal | E | |
| DK2222697T3 | Denmark | T3 | |
| ES2399088T3 | Spain | T3 | |
| SI2222697T1 | Slovenia | T1 | |
| HRP20130194T1 | Croatia | T1 | |
| US8445230B2 | United States of America | B2 | |
| PL2222697T3 | Poland | T3 | |
| CN103172750A | China | A | |
| EP2612867A1 | European Patent Office (EPO) | A1 | |
| EP2612868A1 | European Patent Office (EPO) | A1 | |
| US8491899B2 | United States of America | B2 | |
| US8496935B2 | United States of America | B2 | |
| JP5298134B2 | Japan | B2 | |
| RU2506275C2 | Russian Federation | C2 | |
| CN101998965B | China | B | |
| CA2703263C | Canada | C | |
| KR101383476B1 | Republic of Korea | B1 | |
| TWI448473B | Taiwan Province of China | B | |
| CN103172750B | China | B | |
| CA2805976C | Canada | C | |
| PH12013501101A1 | Philippines | A1 | |
| PH12013501101B1 | Philippines | B1 | |
| IL205036A | Israel | A | |
| CY1113713T1 | Cyprus | T1 | |
| EP2612868B1 | European Patent Office (EPO) | B1 | |
| PT2612868T | Portugal | T | |
| ES2688721T3 | Spain | T3 | |
| PL2612868T3 | Poland | T3 |
13 legal events, as 5 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Entry into the national phaseENP | ENP | BR | |
| Entry into the national phaseENP | ENP | AU | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Entry into the national phaseENP | ENP | KR | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Non-entry into the national phaseNENP | NENP | DE | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)DPE1 | DPE1 | WO | |
| Ep: the epo has been informed by wipo that ep was designated in this application121 | 121 | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO |
Numbers
- Publication
- 2009/058564
- Publication, DOCDB
- 2009058564
- Publication, EPODOC
- WO2009058564
- Application
- 79981
- Application, DOCDB
- 2008079981
- Application, EPODOC
- WO2008US79981
Titles2
- English
- IMMUNOSUPPRESSIVE POLYPEPTIDES AND NUCLEIC ACIDS
- French
- POLYPEPTIDE IMMUNOSUPPRESSEUR ET ACIDES NUCLÉIQUES
Classification
- CPC, 4
- C07K14/70521
- C07K2319/30
- A61P37/00
- A61P37/06
- IPC, 7
- A61K35 12
- A61K35 64
- A61K35 76
- A61K35 761
- A61K35 763
- A61K36 06
- C07K14 705
Designated states142
- Regional, 77
- African Regional Intellectual Property Organization (ARIPO)
- Botswana
- Ghana
- Gambia
- Kenya
- Lesotho
- Malawi
- Mozambique
- Namibia
- Sudan
- Sierra Leone
- Eswatini
- United Republic of Tanzania
- Uganda
- Zambia
- Zimbabwe
- Eurasian Patent Organization (EAPO)
- Armenia
- Azerbaijan
- Belarus
- Kyrgyzstan
- Kazakhstan
- Republic of Moldova
- Russian Federation
and 53 moreShow fewer
- Tajikistan
- Turkmenistan
- European Patent Office (EPO)
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Croatia
- Hungary
- Ireland
- Iceland
- Italy
- Lithuania
- Luxembourg
- Latvia
- Monaco
- Malta
- Netherlands (Kingdom of the)
- Norway
- Poland
- Portugal
- Romania
- Sweden
- Slovenia
- Slovakia
- Türkiye
- African Intellectual Property Organization (OAPI)
- Burkina Faso
- Benin
- Central African Republic
- Congo
- Côte d’Ivoire
- Cameroon
- Gabon
- Guinea
- Equatorial Guinea
- Guinea-Bissau
- Mali
- Mauritania
- Niger
- Senegal
- Chad
- Togo
- National, 65
- United Arab Emirates
- Antigua and Barbuda
- Albania
- Angola
- Australia
- Bosnia and Herzegovina
- Barbados
- Bahrain
- Brazil
- Belize
- Canada
- China
- Colombia
- Costa Rica
- Cuba
- Dominica
- Dominican Republic
- Algeria
- Ecuador
- Egypt
- Grenada
- Georgia
- Guatemala
- Honduras
and 41 moreShow fewer
- Indonesia
- Israel
- India
- Japan
- Comoros
- Saint Kitts and Nevis
- Democratic People’s Republic of Korea
- Republic of Korea
- Lao People’s Democratic Republic
- Saint Lucia
- Sri Lanka
- Liberia
- Libya
- Morocco
- Montenegro
- Madagascar
- North Macedonia
- Mongolia
- Mexico
- Malaysia
- Nigeria
- Nicaragua
- New Zealand
- Oman
- Papua New Guinea
- Philippines
- Serbia
- Seychelles
- Singapore
- San Marino
- Sao Tome and Principe
- El Salvador
- Syrian Arab Republic
- Tunisia
- Trinidad and Tobago
- Ukraine
- United States of America
- Uzbekistan
- Saint Vincent and the Grenadines
- Viet Nam
- South Africa